Trial Profile
The Effect of Vildagliptin on Endothelium-dependent Vasodilatation. A Double Blind Cross-over Study in Type 2 Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 May 2022
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Acarbose
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms VILD1
- 16 Sep 2011 Substudy results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
- 25 Jul 2011 Results published in the Diabetes Care.
- 04 Nov 2010 Actual end date (October 2010) added as reported by ClinicalTrials.gov.